Clinical Pharmacokinetics

Acknowledgement to Referees

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol

Muhammad Bilal, Lobna El Tabei, Sören Büsker, Christian Krauss, Uwe Fuhr, Max Taubert

Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine

Robert Hermann, Peter Krajcsi, Markus Fluck, Annick Seithel-Keuth, Afrim Bytyqi, Andrew Galazka, Alain Munafo

Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review

Camille Lenoir, Frédérique Rodieux, Jules A. Desmeules, Victoria Rollason, Caroline F. Samer

Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events

Xiaofeng Wang, Jack Tseng, Carmen Mak, Nagaraju Poola, Regis A. Vilchez

Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach

Lisa Alina Kneller, Pablo Zubiaur, Dora Koller, Francisco Abad-Santos, Georg Hempel

Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions

Georgios Schoretsanitis, Ekkehard Haen, Daria Piacentino, Andreas Conca, Katharina Endres, Fabio Carpi, Christoph Hiemke, Gerhard Gründer, Michael Paulzen

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

Samit Ganguly, Andrea N. Edginton, Jacqueline G. Gerhart, Michael Cohen-Wolkowiez, Rachel G. Greenberg, Daniel Gonzalez, Daniel K. Benjamin Jr, Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, Rose Beci, Chi Dang Hornik, Gregory L. Kearns, Matthew Laughon, Ian M. Paul, Janice Sullivan, Kelly Wade, Paula Delmore, Perdita Taylor-Zapata, June Lee, Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, Lawrence Taylor, Thomas Green, Anand Kantak, Judy Ohlinger, Mike Horgan, Susan Boynton, Eric C. Eichenwald, Karen Jones, David J. Durand, Jeanette Asselin, Antonio Arrieta, Kathy Shea, Kelly Wade, Tonia Morrison, Beverly S. Brozanski, Robyn Baker, Joern-Hendrik Weitkamp, Millie Nannie, Pablo Sanchez, Shirley Montanye, John van den Anker, Elaine Williams, P. Brian Smith, Michael Cohen-Wolkowiez, Margarita Bidegain, Daniel K. Benjamin Jr, Sandy Grimes, William MacKendrick, Sue Wolf, Brenda Poindexter, Leslie Dawn Wilson, Lisa M. Castro, Ann Harris, Venkataraman Balaraman, Robyn Morse, Maynard Rasmussen, Kathy Arnell, Gloria Valencia, Sara Higgerson, Michele Walsh, Arlene Zadell, Claire M. Roane, Neil Finer, Edmund V. Capparelli, Wade Rich, David Burchfield, Cindy Miller, Janice E. Sullivan, Gwendolyn Pierce, Varsha Bhatt-Mehta, Ron Dechert, Robert M. Ward, JoAnn Narus, Mathew Bizzaro, Monica Konstantino

A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension

Roberta Bartolucci, Anne-Gaëlle Dosne, Dénes Csonka, Juan José Pérez-Ruixo, Paolo Magni, Italo Poggesi

Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Ken Ogasawara, Michael Dodds, Timothy Mack, James Lymp, Justine Dell’Aringa, Jeff Smith

Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Ken Ogasawara, Michael Dodds, Timothy Mack, James Lymp, Justine Dell’Aringa, Jeff Smith